Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis
Jeanine Flanigan(Sanden (Japan)), GH Lyman(Duke University), Marion Schauf, Lamees Almuallem(EVERSANA (Canada)), A Zhou(EVERSANA (Canada)), Mike Tindal(Sanden (Japan)), Edward Li(Sanden (Japan)), Sarah Kane(EVERSANA (Canada)), Fatemeh Mirzayeh Fashami(EVERSANA (Canada))
Cited by 1
Related Papers
Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic Development
|Developmental Cell|2008|231
Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
|The Journal of Cell Biology|2017|175
Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database
|BMC Public Health|2018|85
Projecting future drug expenditures—2012
|American Journal of Health-System Pharmacy|2012|81